Super Memory Formula

Natural Treatment for Alzheimer Discovered

Get Instant Access

Calingasan NY, Uchida K, Gibson GE (1999) Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72, 751-6.

Cras P, Smith MA, Richey PL, Siedlak SL, Mulvihill P, Perry G (1995) Extracellular neurofibrillary tangles reflect neuronal loss and provide further evidence of extensive protein cross-linking in Alzheimer disease. Acta Neuropathol 89, 291-5.

Dowson JH, Mountjoy CQ, Cairns MR, Wilton-Cox H, Bondareff W (1998) Lipopigment changes in Purkinje cells in Alzheimer's disease. J Alzheimer's Dis 1, 71-9.

Friguet B, Stadtman ER, Szweda LI (1994) Modification of glucose-6-phosphate dehydrogenase by 4-hydroxy-2-nonenal. Formation of cross-linked protein that inhibits the multicatalytic protease. J Biol Chem 269, 21639-43.

Gibson GE, Sheu KF, Blass JP (1998) Abnormalities of mitochondrial enzymes in Alzheimer disease. J Neur Transm 105, 855-70.

Kalaria RN, Gravina SA, Schmidley JW, Perry G, Harik SI (1988) The glucose transporter of the human brain and blood-brain barrier. Ann Neurol 24, 757-64.

Ledesma MD, Bonay P, Colaco C, Avila J (1994) Analysis of microtubule-associated protein tau glycation in paired helical filaments. J Biol Chem 269, 21614-19.

Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 158, 4752.

Markesbery WR (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Rad Biol Med 23, 134-47.

Martins RN, Harper CG, Stokes GB, Masters CL (1986) Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J Neurochem 46, 1042-5.

Mattson MP, Carney JW, Butterfield DA (1995) A tombstone in Alzheimer's? Nature 373, 481.

Montine TJ, Amarnath V, Martin ME, Strittmatter WJ, Graham DG (1996) E-4-hydroxy-2-nonenal is cytotoxic and cross-links cytoskeletal proteins in P19 neuroglial cultures. Am J Pathol 148, 89-93.

Mori H, Kondo J, Ihara Y (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 1641-44.

Nunomura A, Perry G, Hirai K et al. (1999b) Neuronal RNA oxidation in Alzheimer's disease and Down's syndrome. Ann NY Acad Sci 893, 362-4.

Nunomura A, Perry G, Hirai K, Chiba S, Smith MA (2000) Neuronal oxidative stress precedes amyloid-ß deposition in Down's syndrome. J Neuropathol Exp Neurol 59, 1011-17.

Nunomura A, Perry G, Pappolla MA et al. (1999a) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J Neurosci 19, 1959-64.

Odetti P, Angelini G, Dapino D et al. (1998) Early glycoxidation damage in brains from Down's syndrome. Biochem Biophys Res Commun 243, 849-51.

Perry G, Friedman R, Shaw G, Chau V (1987) Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains. Proc Natl Acad Sci USA 84, 3033-6.

Perry G, Roder H, Nunomura A et al. (1999) Activation of neuronal extracellular receptor kinase (ERK) in Alzheimer disease links oxidative stress to abnormal phosphorylation. Neuroreport 10, 2411-15.

Premkumar DRD, Smith MA, Richey PL et al. (1995) Induction of heme oxygenase-1 mRNA and protein in neocortex and cerebral vessels in Alzheimer's disease. J Neurochem 65, 1399-402.

Russell RL, Siedlak SL, Raina AK, Bautista JM, Smith MA, Perry G (1999) Increased neuronal glucose-6-phosphate dehydrogenase and sulfhydryl levels indicate reductive compensation to oxidative stress in Alzheimer disease. Arch Biochem Biophys 370, 236-9.

Sayre LM, Perry G, Harris PLR, Liu Y, Schubert KA, Smith MA (2000) In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer disease: a central role for bound transition metals. J Neurochem 74, 270-9.

Sayre LM, Zelasko DA, Harris PLR, Perry G, Salomon RG, Smith MA (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J Neurochem 68, 2092-7.

Small GW, Komo S, La Rue A et al. (1996) Early detection of Alzheimer's disease by combining apolipoprotein E and neuroimaging. Ann NY Acad Sci 802, 70-8.

Smith CD, Carney JM, Tatsumo T, Stadtman ER, Floyd RA, Markesbery WR (1992) Protein oxidation in aging brain. Ann NY Acad Sci 663, 110-19.

Smith MA, Harris PLR, Sayre LM, Perry G (1999) Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 94, 9866-8.

Smith MA, Rudnicka-Nawrot M, Richey PL et al. (1995) Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer's disease. J Neurochem 64, 2660-6.

Smith MA, Taneda S, Richey PL et al. (1994a) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91, 5710-14.

Smith MA, Kutty RK, Richey PL et al. (1994b) Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease. Am J Pathol 145, 42-7.

Takeda A, Perry G, Abraham NG et al. (2000a) Overexpression of heme oxygenase in neuronal cells, the possible interaction with tau. J Biol Chem 275, 5395-9.

Takeda A, Smith MA, Avila J et al. (2000b) In Alzheimer disease, heme oxygenase is coincident with Alz50, an epitope of tau induced by 4-hydroxy-2-nonenal modification. J Neurochem 75, 1234-41.

Vitek MP, Bhattacharya K, Glendening JM et al. (1994) Advanced glycation end products contribute to amyloidosis in Alzheimer disease. Proc Natl Acad Sci USA 91, 4766-70.

Wong-Riley M, Antuono P, Ho K-V et al. (1997) Cytochrome oxidase in Alzheimer's disease: biochemical, histochemical, and immunohistochemical analyses of the visual and other systems. Vision Res 37, 3593-608.

Yan S-D, Chen X, Schmidt A-M et al. (1994) Glycated tau protein in Alzheimer disease: a mechanism for induction of oxidant stress. Proc Natl Acad Sci USA 91, 7787-91.

Zhu X, Raina AK, Boux H, Takeda A, Perry G, Smith MA (2000) Activation of p38 pathway links tau phosphorylation, oxidative stress and cell cycle-related events in Alzheimer disease. J Neuropathol Exp Neurol 59, 880-88.

Address for correspondence: George Perry, Institute of Pathology, Case Western Reserve University, 2085 Adelbert Road, Cleveland, OH 44106-2622, USA Tel: 216-368-2488; fax: 216-368-8964; e-mail: [email protected]

Alzheimer's Disease: Advances in Etiology, Pathogenesis and Therapeutics Edited by Khalid Iqbal, Sangram S. Sisodia and Bengt Winblad Copyright © 2001 John Wiley & Sons Ltd Print ISBN 0-471-52176-0 Online ISBN 0-470-84645-3

35 Cyclooxygenase (COX)-2 and Clinical Progression of Alzheimer's Disease Dementia: Implications in the Role of Neuronal COX-2 in Cell Cycle


Was this article helpful?

0 0
All About Alzheimers

All About Alzheimers

The comprehensive new ebook All About Alzheimers puts everything into perspective. Youll gain insight and awareness into the disease. Learn how to maintain the patients emotional health. Discover tactics you can use to deal with constant life changes. Find out how counselors can help, and when they should intervene. Learn safety precautions that can protect you, your family and your loved one. All About Alzheimers will truly empower you.

Get My Free Ebook

Post a comment